{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T10:51:30Z","timestamp":1792320690421,"version":"4.4.0"},"reference-count":91,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","ackdjournal.org","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Advances in Chronic Kidney Disease"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1053\/j.ackd.2018.01.005","type":"journal-article","created":{"date-parts":[[2018,5,22]],"date-time":"2018-05-22T03:11:15Z","timestamp":1526958675000},"page":"267-273","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Magnesium and Drugs Commonly Used in Chronic Kidney Disease"],"prefix":"10.1053","volume":"25","author":[{"given":"Jeffrey H.","family":"William","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katelyn","family":"Richards","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Danziger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1053\/j.ackd.2018.01.005_bib1","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1053\/j.ajkd.2015.05.012","article-title":"Proton pump inhibitors and hypomagnesemia in the general population: a population-based cohort study","volume":"66","author":"Kieboom","year":"2015","journal-title":"Am J Kidney Dis"},{"issue":"7","key":"10.1053\/j.ackd.2018.01.005_bib2","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.3109\/0886022X.2015.1057800","article-title":"Proton pump inhibitors linked to hypomagnesemia: a systematic review and meta-analysis of observational studies","volume":"37","author":"Cheungpasitporn","year":"2015","journal-title":"Ren Fail"},{"issue":"2","key":"10.1053\/j.ackd.2018.01.005_bib3","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1111\/j.1365-2265.2008.03194.x","article-title":"Severe hypomagnesaemia in long-term users of proton-pump inhibitors","volume":"69","author":"Cundy","year":"2008","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"1","key":"10.1053\/j.ackd.2018.01.005_bib4","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1186\/s12882-015-0139-9","article-title":"The relationship between proton pump inhibitor use and serum magnesium concentration among hemodialysis patients: a cross-sectional study","volume":"16","author":"Misra","year":"2015","journal-title":"BMC Nephrol"},{"issue":"3","key":"10.1053\/j.ackd.2018.01.005_bib5","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1159\/000360011","article-title":"Hypomagnesemia in hemodialysis patients: role of proton pump inhibitors","volume":"39","author":"Alhosaini","year":"2014","journal-title":"Am J Nephrol"},{"issue":"12","key":"10.1053\/j.ackd.2018.01.005_bib6","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1111\/nep.12330","article-title":"Proton-pump inhibitor use is associated with lower urinary magnesium excretion","volume":"19","author":"William","year":"2014","journal-title":"Nephrology (Carlton)"},{"issue":"11","key":"10.1053\/j.ackd.2018.01.005_bib7","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1007\/s00424-013-1306-0","article-title":"Omeprazole enhances the colonic expression of the Mg2+ transporter TRPM6","volume":"465","author":"Lameris","year":"2013","journal-title":"Pflugers Arch"},{"issue":"4","key":"10.1053\/j.ackd.2018.01.005_bib8","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1038\/ki.2012.452","article-title":"Proton-pump inhibitor use is associated with low serum magnesium concentrations","volume":"83","author":"Danziger","year":"2013","journal-title":"Kidney Int"},{"key":"10.1053\/j.ackd.2018.01.005_bib9","first-page":"515","article-title":"Effects of proton pump inhibitors and electrolyte disturbances on arrhythmias","volume":"6","author":"El-Charabaty","year":"2013","journal-title":"Int J Gen Med"},{"issue":"7","key":"10.1053\/j.ackd.2018.01.005_bib10","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1002\/jcph.479","article-title":"Proton pump inhibitor use is not associated with cardiac arrhythmia in critically ill patients","volume":"55","author":"Chen","year":"2015","journal-title":"J Clin Pharmacol"},{"issue":"2","key":"10.1053\/j.ackd.2018.01.005_bib11","first-page":"385","article-title":"Primary hypomagnesemia with secondary hypocalcemia in an infant","volume":"41","author":"Paunier","year":"1968","journal-title":"Pediatrics"},{"issue":"3","key":"10.1053\/j.ackd.2018.01.005_bib12","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1097\/FPC.0000000000000259","article-title":"Common single nucleotide polymorphisms in transient receptor potential melastatin type 6 increase the risk for proton pump inhibitor-induced hypomagnesemia: a case-control study","volume":"27","author":"Hess","year":"2017","journal-title":"Pharmacogenet Genomics"},{"issue":"10","key":"10.1053\/j.ackd.2018.01.005_bib13","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1056\/NEJM199903113401004","article-title":"Liposomal amphotericin B for empirical therapy in patients with persistent fever and neutropenia. National Institute of Allergy and Infectious Diseases Mycoses Study Group","volume":"340","author":"Walsh","year":"1999","journal-title":"N Engl J Med"},{"issue":"10","key":"10.1053\/j.ackd.2018.01.005_bib14","doi-asserted-by":"crossref","first-page":"8592","DOI":"10.3390\/nu7105416","article-title":"Association of Proton Pump Inhibitor (PPI) use with energy intake, physical activity, and weight gain","volume":"7","author":"Czwornog","year":"2015","journal-title":"Nutrients"},{"issue":"2","key":"10.1053\/j.ackd.2018.01.005_bib15","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s11606-012-2211-5","article-title":"Confounding in the association of proton pump inhibitor use with risk of community-acquired pneumonia","volume":"28","author":"Jena","year":"2013","journal-title":"J Gen Intern Med"},{"issue":"2","key":"10.1053\/j.ackd.2018.01.005_bib16","doi-asserted-by":"crossref","first-page":"104","DOI":"10.5152\/tjg.2016.0284","article-title":"Proton pump inhibitor use for 12 months is not associated with changes in serum magnesium levels: a prospective open label comparative study","volume":"28","author":"Bahtiri","year":"2017","journal-title":"Turkish J Gastroenterol"},{"issue":"2","key":"10.1053\/j.ackd.2018.01.005_bib17","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1001\/jamainternmed.2015.7193","article-title":"Proton pump inhibitor use and the risk of chronic kidney disease","volume":"21205","author":"Lazarus","year":"2016","journal-title":"JAMA Intern Med"},{"issue":"4","key":"10.1053\/j.ackd.2018.01.005_bib18","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1053\/j.gastro.2017.01.031","article-title":"The risks and benefits of long-term use of proton pump inhibitors: expert review and best practice advice from the American Gastroenterological association","volume":"152","author":"Freedberg","year":"2017","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1053\/j.ackd.2018.01.005_bib19","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1177\/0885066604271539","article-title":"Magnesium deficiency in critical illness","volume":"20","author":"Tong","year":"2005","journal-title":"J Intensive Care Med"},{"issue":"2","key":"10.1053\/j.ackd.2018.01.005_bib20","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1001\/jama.2015.7446","article-title":"Effect of patiromer on serum potassium level in patients with hyperkalemia and diabetic kidney disease: the AMETHYST-DN randomized clinical trial","volume":"314","author":"Bakris","year":"2015","journal-title":"JAMA"},{"issue":"4","key":"10.1053\/j.ackd.2018.01.005_bib21","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1002\/phar.1906","article-title":"Systematic review and meta-analysis of patiromer and sodium zirconium cyclosilicate: a new armamentarium for the treatment of hyperkalemia","volume":"37","author":"Meaney","year":"2017","journal-title":"Pharmacotherapy"},{"issue":"4","key":"10.1053\/j.ackd.2018.01.005_bib22","first-page":"F340","article-title":"Effect of furosemide on calcium and magnesium transport in the rat nephron","volume":"241","author":"Quamme","year":"1981","journal-title":"Am J Physiol"},{"issue":"4","key":"10.1053\/j.ackd.2018.01.005_bib23","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1038\/ki.1997.141","article-title":"Cellular mechanisms of chlorothiazide and cellular potassium depletion on Mg2+ uptake in mouse distal convoluted tubule cells","volume":"51","author":"Dai","year":"1997","journal-title":"Kidney Int"},{"issue":"6","key":"10.1053\/j.ackd.2018.01.005_bib24","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1172\/JCI24134","article-title":"Enhanced passive Ca2+ reabsorption and reduced Mg2+ channel abundance explains thiazide-induced hypocalciuria and hypomagnesemia","volume":"115","author":"Nijenhuis","year":"2005","journal-title":"J Clin Invest"},{"issue":"1","key":"10.1053\/j.ackd.2018.01.005_bib25","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/j.0954-6820.1988.tb16734.x","article-title":"Amiloride prevents thiazide-induced intracellular potassium and magnesium losses","volume":"224","author":"Dyckner","year":"1988","journal-title":"Acta Med Scand"},{"issue":"2 Pt 2","key":"10.1053\/j.ackd.2018.01.005_bib26","first-page":"F249","article-title":"Mechanisms of amiloride stimulation of Mg2+ uptake in immortalized mouse distal convoluted tubule cells","volume":"272","author":"Dai","year":"1997","journal-title":"Am J Physiol"},{"issue":"3-4","key":"10.1053\/j.ackd.2018.01.005_bib27","first-page":"201","article-title":"Magnesium homeostasis in critically ill patients","volume":"8","author":"Ryzen","year":"1989","journal-title":"Magnesium"},{"issue":"1","key":"10.1053\/j.ackd.2018.01.005_bib28","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/BF00202170","article-title":"Aminoglycosides: single or multiple daily dosing? A meta-analysis on efficacy and safety","volume":"48","author":"Galloe","year":"1995","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1053\/j.ackd.2018.01.005_bib29","doi-asserted-by":"crossref","first-page":"219","DOI":"10.2147\/IJNRD.S42054","article-title":"Hypomagnesemia: a clinical perspective","volume":"7","author":"Pham","year":"2014","journal-title":"Int J Nephrol Renovasc Dis"},{"issue":"2","key":"10.1053\/j.ackd.2018.01.005_bib30","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1053\/jcrc.2003.50003","article-title":"A study of once-daily amikacin with low peak target concentrations in intensive care unit patients: pharmacokinetics and associated outcomes","volume":"18","author":"Bacopoulou","year":"2003","journal-title":"J Crit Care"},{"issue":"8","key":"10.1053\/j.ackd.2018.01.005_bib31","doi-asserted-by":"crossref","first-page":"717","DOI":"10.7326\/0003-4819-124-8-199604150-00003","article-title":"Once-daily aminoglycoside dosing in immunocompetent adults: a meta-analysis","volume":"124","author":"Hatala","year":"1996","journal-title":"Ann Intern Med"},{"issue":"5","key":"10.1053\/j.ackd.2018.01.005_bib32","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/S0002-9343(89)80612-6","article-title":"Risk factors for Amphotericin B-associated nephrotoxicity","volume":"87","author":"Fisher","year":"1989","journal-title":"Am J Med"},{"issue":"9","key":"10.1053\/j.ackd.2018.01.005_bib33","doi-asserted-by":"crossref","first-page":"763","DOI":"10.2165\/00002018-200528090-00003","article-title":"Drug-induced hypomagnesaemia\u202f: scope and management","volume":"28","author":"Atsmon","year":"2005","journal-title":"Drug Saf"},{"issue":"7","key":"10.1053\/j.ackd.2018.01.005_bib34","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/S0002-9343(01)00928-7","article-title":"The epidemiology of nephrotoxicity associated with conventional amphotericin B therapy","volume":"111","author":"Harbarth","year":"2001","journal-title":"Am J Med"},{"issue":"1","key":"10.1053\/j.ackd.2018.01.005_bib35","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1345\/aph.19127","article-title":"Amiloride for the prevention of amphotericin B-induced hypokalemia and hypomagnesemia","volume":"34","author":"Wazny","year":"2000","journal-title":"Ann Pharmacother"},{"issue":"11","key":"10.1053\/j.ackd.2018.01.005_bib36","doi-asserted-by":"crossref","first-page":"2496","DOI":"10.1128\/AAC.37.11.2496","article-title":"Use of human renal proximal tubule cell cultures for studying foscarnet-induced nephrotoxicity in\u00a0vitro","volume":"37","author":"Trifillis","year":"1993","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"10.1053\/j.ackd.2018.01.005_bib37","doi-asserted-by":"crossref","first-page":"199","DOI":"10.2165\/00003495-199448020-00007","article-title":"Foscarnet. A reappraisal of its antiviral activity, pharmacokinetic properties and therapeutic use in immunocompromised patients with viral infections","volume":"48","author":"Wagstaff","year":"1994","journal-title":"Drugs"},{"issue":"1","key":"10.1053\/j.ackd.2018.01.005_bib38","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1053\/j.ajkd.2014.07.024","article-title":"Intravascular foscarnet crystal precipitation causing multiorgan failure","volume":"65","author":"Philipponnet","year":"2015","journal-title":"Am J Kidney Dis"},{"issue":"4","key":"10.1053\/j.ackd.2018.01.005_bib39","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1086\/597645","article-title":"Unusual prolonged hypocalcemia due to foscarnet in a patient with AIDS","volume":"25","author":"Guillaume","year":"1997","journal-title":"Clin Infect Dis"},{"issue":"8","key":"10.1053\/j.ackd.2018.01.005_bib40","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1097\/TP.0b013e31822d87e8","article-title":"Effect of cinacalcet on renal electrolyte handling and systemic arterial blood pressure in kidney transplant patients with persistent hyperparathyroidism","volume":"92","author":"Zitt","year":"2011","journal-title":"Transplantation"},{"issue":"OC3.2","key":"10.1053\/j.ackd.2018.01.005_bib41","article-title":"Changes in serum magnesium levels during cinacalcet therapy for primary hyperparathyroidism","volume":"26","author":"Daraki","year":"2011","journal-title":"Endocr Abstr"},{"issue":"10","key":"10.1053\/j.ackd.2018.01.005_bib42","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.4009\/jsdt.44.1007","article-title":"Effects of cinacalcet on magnesium and potassium metabolism in peritoneal dialysis patients with residual renal function","volume":"44","author":"Shibata","year":"2011","journal-title":"Nihon Toseki Igakkai Zasshi"},{"issue":"3 Pt 1","key":"10.1053\/j.ackd.2018.01.005_bib43","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1111\/j.1399-0012.1995.tb00320.x","article-title":"Hypomagnesemia in renal transplant patients: improvement over time and association with hypertension and cyclosporine levels","volume":"9","author":"Ramos","year":"1995","journal-title":"Clin Transplant"},{"issue":"4","key":"10.1053\/j.ackd.2018.01.005_bib44","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/0002-9343(87)90900-4","article-title":"Hypomagnesemia and renal magnesium wasting in renal transplant recipients receiving cyclosporine","volume":"83","author":"Barton","year":"1987","journal-title":"Am J Med"},{"issue":"8412","key":"10.1053\/j.ackd.2018.01.005_bib45","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1016\/S0140-6736(84)91556-3","article-title":"Association between cyclosporin neurotoxicity and hypomagnesaemia","volume":"2","author":"Thompson","year":"1984","journal-title":"Lancet"},{"issue":"3","key":"10.1053\/j.ackd.2018.01.005_bib46","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1097\/TP.0b013e31817fe069","article-title":"Impact of cyclosporine A on magnesium homeostasis: clinical observation in lung transplant recipients and experimental study in mice","volume":"86","author":"Sabbagh","year":"2008","journal-title":"Transplantation"},{"issue":"3","key":"10.1053\/j.ackd.2018.01.005_bib47","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1097\/01.ASN.0000113318.56023.B6","article-title":"Downregulation of Ca(2+) and Mg(2+) transport proteins in the kidney explains tacrolimus (FK506)-induced hypercalciuria and hypomagnesemia","volume":"15","author":"Nijenhuis","year":"2004","journal-title":"J Am Soc Nephrol"},{"issue":"4","key":"10.1053\/j.ackd.2018.01.005_bib48","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1038\/ki.1996.417","article-title":"Comparison of acute rapamycin nephrotoxicity with cyclosporine and FK506","volume":"50","author":"Andoh","year":"1996","journal-title":"Kidney Int"},{"issue":"9","key":"10.1053\/j.ackd.2018.01.005_bib49","doi-asserted-by":"crossref","first-page":"2140","DOI":"10.1111\/j.1600-6143.2009.02752.x","article-title":"Posttransplantation hypomagnesemia and its relation with immunosuppression as predictors of new-onset diabetes after transplantation","volume":"9","author":"Van Laecke","year":"2009","journal-title":"Am J Transplant"},{"issue":"4","key":"10.1053\/j.ackd.2018.01.005_bib50","doi-asserted-by":"crossref","first-page":"F916","DOI":"10.1152\/ajprenal.90256.2008","article-title":"Rosiglitazone prevents sirolimus-induced hypomagnesemia, hypokalemia, and downregulation of NKCC2 protein expression","volume":"297","author":"da Silva","year":"2009","journal-title":"Am J Physiol Renal Physiol"},{"issue":"6","key":"10.1053\/j.ackd.2018.01.005_bib51","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1016\/j.bbamem.2010.11.006","article-title":"Decrease in transient receptor potential melastatin 6 mRNA stability caused by rapamycin in renal tubular epithelial cells","volume":"1808","author":"Ikari","year":"2011","journal-title":"Biochim Biophys Acta"},{"issue":"1","key":"10.1053\/j.ackd.2018.01.005_bib52","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1053\/ctrv.1999.0097","article-title":"Cisplatin and hypomagnesemia","volume":"25","author":"Lajer","year":"1999","journal-title":"Cancer Treat Rev"},{"issue":"6","key":"10.1053\/j.ackd.2018.01.005_bib53","doi-asserted-by":"crossref","first-page":"929","DOI":"10.7326\/0003-4819-90-6-929","article-title":"Hypomagnesemia and renal magnesium wasting in patients receiving cisplatin","volume":"90","author":"Schilsky","year":"1979","journal-title":"Ann Intern Med"},{"issue":"5","key":"10.1053\/j.ackd.2018.01.005_bib54","first-page":"254","article-title":"Renal excretion of magnesium and trace elements during cisplatin treatment","volume":"17","author":"Zumkley","year":"1982","journal-title":"Clin Nephrol"},{"issue":"2","key":"10.1053\/j.ackd.2018.01.005_bib55","doi-asserted-by":"crossref","first-page":"e57016","DOI":"10.1371\/journal.pone.0057016","article-title":"The TRPM6\/EGF pathway is downregulated in a rat model of cisplatin nephrotoxicity","volume":"8","author":"Ledeganck","year":"2013","journal-title":"PLoS One"},{"issue":"10","key":"10.1053\/j.ackd.2018.01.005_bib56","first-page":"CR524","article-title":"Effects of acute magnesium loading on pulmonary function of stable COPD patients","volume":"14","author":"do Amaral","year":"2008","journal-title":"Med Sci Monit"},{"issue":"2","key":"10.1053\/j.ackd.2018.01.005_bib57","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1038\/sj.bjc.6690697","article-title":"Dose-related nephrotoxicity of carboplatin in children","volume":"81","author":"English","year":"1999","journal-title":"Br J Cancer"},{"issue":"2","key":"10.1053\/j.ackd.2018.01.005_bib58","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1002\/pbc.20812","article-title":"Nephrotoxicity of cisplatin and carboplatin in sarcoma patients: a report from the late effects surveillance system","volume":"48","author":"Stohr","year":"2007","journal-title":"Pediatr Blood Cancer"},{"issue":"28","key":"10.1053\/j.ackd.2018.01.005_bib59","doi-asserted-by":"crossref","first-page":"11324","DOI":"10.1073\/pnas.1113811109","article-title":"Loss of insulin-induced activation of TRPM6 magnesium channels results in impaired glucose tolerance during pregnancy","volume":"109","author":"Nair","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"16","key":"10.1053\/j.ackd.2018.01.005_bib60","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1093\/jnci\/dji242","article-title":"Cetuximab therapy and symptomatic hypomagnesemia","volume":"97","author":"Schrag","year":"2005","journal-title":"J Natl Cancer Inst"},{"issue":"5","key":"10.1053\/j.ackd.2018.01.005_bib61","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S1470-2045(07)70108-0","article-title":"Magnesium wasting associated with epidermal-growth-factor receptor-targeting antibodies in colorectal cancer: a prospective study","volume":"8","author":"Tejpar","year":"2007","journal-title":"Lancet Oncol"},{"issue":"114","key":"10.1053\/j.ackd.2018.01.005_bib62","first-page":"366","article-title":"Hypomagnesaemia in patients with metastatic colorectal carcinoma treated with cetuximab","volume":"59","author":"Melichar","year":"2012","journal-title":"Hepatogastroenterology"},{"key":"10.1053\/j.ackd.2018.01.005_bib63","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1517\/14740338.2011.606213","article-title":"Risk of anti-EGFR monoclonal antibody-related hypomagnesemia: systematic review and pooled analysis of randomized studies","volume":"11 Suppl 1","author":"Petrelli","year":"2012","journal-title":"Expert Opin Drug Saf"},{"issue":"23","key":"10.1053\/j.ackd.2018.01.005_bib64","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1093\/jnci\/dji412","article-title":"Re: cetuximab therapy and symptomatic hypomagnesemia","volume":"97","author":"Altundag","year":"2005","journal-title":"J Natl Cancer Inst"},{"issue":"1","key":"10.1053\/j.ackd.2018.01.005_bib65","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1097\/FJC.0000000000000163","article-title":"EGFR-TKI, erlotinib, causes hypomagnesemia, oxidative stress, and cardiac dysfunction: attenuation by NK-1 receptor blockade","volume":"65","author":"Mak","year":"2015","journal-title":"J\u00a0Cardiovasc Pharmacol"},{"issue":"11","key":"10.1053\/j.ackd.2018.01.005_bib66","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.1097\/HJH.0b013e3283642f18","article-title":"Association of hypermagnesemia and blood pressure in the critically ill","volume":"31","author":"Celi","year":"2013","journal-title":"J Hypertens"},{"issue":"2","key":"10.1053\/j.ackd.2018.01.005_bib67","first-page":"157","article-title":"Therapeutic uses of magnesium","volume":"80","author":"Guerrera","year":"2009","journal-title":"Am Fam Physician"},{"key":"10.1053\/j.ackd.2018.01.005_bib68","series-title":"Milk of Magnesia [package insert]","year":"2016"},{"key":"10.1053\/j.ackd.2018.01.005_bib69","series-title":"Epsom Salt [package insert]","year":"2016"},{"key":"10.1053\/j.ackd.2018.01.005_bib70","series-title":"MoviPrep [package insert]","year":"2016"},{"key":"10.1053\/j.ackd.2018.01.005_bib71","series-title":"GoLytely [package insert]","year":"2013"},{"key":"10.1053\/j.ackd.2018.01.005_bib72","series-title":"NuLytely [package insert]","year":"2013"},{"key":"10.1053\/j.ackd.2018.01.005_bib73","series-title":"Magnesium citrate [package insert]","year":"2011"},{"key":"10.1053\/j.ackd.2018.01.005_bib74","series-title":"CoLyte [package insert]","year":"2013"},{"key":"10.1053\/j.ackd.2018.01.005_bib75","series-title":"GaviLyte-H [package insert]","year":"2014"},{"key":"10.1053\/j.ackd.2018.01.005_bib76","series-title":"SuPrep [package insert]","year":"2012"},{"issue":"4","key":"10.1053\/j.ackd.2018.01.005_bib77","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/0735-6757(90)90078-E","article-title":"Serum magnesium concentrations after repetitive magnesium cathartic administration","volume":"8","author":"Woodard","year":"1990","journal-title":"Am J Emerg Med"},{"issue":"5","key":"10.1053\/j.ackd.2018.01.005_bib78","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1159\/000168469","article-title":"Unsuspected morbid hypermagnesemia in elderly patients","volume":"12","author":"Clark","year":"1992","journal-title":"Am J Nephrol"},{"issue":"1","key":"10.1053\/j.ackd.2018.01.005_bib79","first-page":"61","article-title":"Fatal hypermagnesemia","volume":"53","author":"Schelling","year":"2000","journal-title":"Clin Nephrol"},{"issue":"5","key":"10.1053\/j.ackd.2018.01.005_bib80","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/S0196-0644(96)70120-8","article-title":"Acute hypermagnesemia after laxative use","volume":"28","author":"Qureshi","year":"1996","journal-title":"Ann Emerg Med"},{"issue":"1","key":"10.1053\/j.ackd.2018.01.005_bib81","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1097\/01.SMJ.0000049844.49028.1D","article-title":"Severe hypermagnesemia as a result of laxative use in renal insufficiency","volume":"96","author":"Zaman","year":"2003","journal-title":"South Med J"},{"issue":"2","key":"10.1053\/j.ackd.2018.01.005_bib82","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0736-4679(01)00462-0","article-title":"Hypermagnesemia-induced fatality following epsom salt gargles(1)","volume":"22","author":"Birrer","year":"2002","journal-title":"J Emerg Med"},{"issue":"14","key":"10.1053\/j.ackd.2018.01.005_bib83","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1001\/jama.1934.02750140024010","article-title":"Clinical manifestations of high and low plasma magnesium: dangers of epsom salt purgation in nephritis","volume":"102","author":"Hirschfelder","year":"1934","journal-title":"JAMA"},{"issue":"2","key":"10.1053\/j.ackd.2018.01.005_bib84","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0196-0644(89)80112-X","article-title":"Dead Sea water poisoning","volume":"18","author":"Porath","year":"1989","journal-title":"Ann Emerg Med"},{"key":"10.1053\/j.ackd.2018.01.005_bib85","doi-asserted-by":"crossref","first-page":"215","DOI":"10.2147\/CEG.S79216","article-title":"Serum magnesium concentrations in patients receiving sodium picosulfate and magnesium citrate bowel preparation: an assessment of renal function and electrocardiographic conduction","volume":"8","author":"Bertiger","year":"2015","journal-title":"Clin Exp Gastroenterol"},{"issue":"3","key":"10.1053\/j.ackd.2018.01.005_bib86","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1007\/s00330-009-1575-3","article-title":"Bowel preparation in CT colonography: electrolyte and renal function disturbances in the frail and elderly patient","volume":"20","author":"Mc Laughlin","year":"2010","journal-title":"Eur Radiol"},{"issue":"11","key":"10.1053\/j.ackd.2018.01.005_bib87","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1136\/gutjnl-2011-300861","article-title":"Consensus guidelines for the safe prescription and administration of oral bowel-cleansing agents","volume":"61","author":"Connor","year":"2012","journal-title":"Gut"},{"issue":"3","key":"10.1053\/j.ackd.2018.01.005_bib88","doi-asserted-by":"crossref","first-page":"219","DOI":"10.5946\/ce.2013.46.3.219","article-title":"Optimal and safe bowel preparation for colonoscopy","volume":"46","author":"Moon","year":"2013","journal-title":"Clin Endosc"},{"issue":"7385","key":"10.1053\/j.ackd.2018.01.005_bib89","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1136\/bmj.326.7385.382","article-title":"Fatal dysnatraemia caused by elective colonoscopy","volume":"326","author":"Ayus","year":"2003","journal-title":"BMJ"},{"issue":"3","key":"10.1053\/j.ackd.2018.01.005_bib90","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1093\/ckj\/sfw021","article-title":"Sevelamer carbonate reduces the risk of hypomagnesemia in hemodialysis-requiring end-stage renal disease patients","volume":"9","author":"Rosa-Diez","year":"2016","journal-title":"Clin Kidney J"},{"issue":"2","key":"10.1053\/j.ackd.2018.01.005_bib91","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/s11255-004-7135-5","article-title":"Increase in serum magnesium level in haemodialysis patients receiving sevelamer hydrochloride","volume":"37","author":"Mitsopoulos","year":"2005","journal-title":"Int Urol Nephrol"}],"container-title":["Advances in Chronic Kidney Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1548559518300053?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1548559518300053?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,4]],"date-time":"2025-07-04T17:30:59Z","timestamp":1751650259000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1548559518300053"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5]]},"references-count":91,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,5]]}},"alternative-id":["S1548559518300053"],"URL":"https:\/\/doi.org\/10.1053\/j.ackd.2018.01.005","relation":{},"ISSN":["1548-5595"],"issn-type":[{"value":"1548-5595","type":"print"}],"subject":[],"published":{"date-parts":[[2018,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Magnesium and Drugs Commonly Used in Chronic Kidney Disease","name":"articletitle","label":"Article Title"},{"value":"Advances in Chronic Kidney Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.ackd.2018.01.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 by the National Kidney Foundation, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}